302 related articles for article (PubMed ID: 26671825)
1. Hyperuricemia and nonalcoholic fatty liver disease: from bedside to bench and back.
Xu C
Hepatol Int; 2016 Mar; 10(2):286-93. PubMed ID: 26671825
[TBL] [Abstract][Full Text] [Related]
2. Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: One stone hits two birds.
Xu C; Wan X; Xu L; Weng H; Yan M; Miao M; Sun Y; Xu G; Dooley S; Li Y; Yu C
J Hepatol; 2015 Jun; 62(6):1412-9. PubMed ID: 25623823
[TBL] [Abstract][Full Text] [Related]
3. [Studies on association between nonalcoholic fatty liver disease and hyperuricemia: current status and future prospects].
Li Y
Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):89-91. PubMed ID: 26983473
[TBL] [Abstract][Full Text] [Related]
4. Serum uric acid: a new therapeutic target for nonalcoholic fatty liver disease.
Sun DQ; Wu SJ; Liu WY; Lu QD; Zhu GQ; Shi KQ; Braddock M; Song D; Zheng MH
Expert Opin Ther Targets; 2016; 20(3):375-87. PubMed ID: 26419119
[TBL] [Abstract][Full Text] [Related]
5. Liver Fat Content Is Associated with Elevated Serum Uric Acid in the Chinese Middle-Aged and Elderly Populations: Shanghai Changfeng Study.
Lin H; Li Q; Liu X; Ma H; Xia M; Wang D; Li X; Wu J; Zhao N; Pan B; Gao X
PLoS One; 2015; 10(10):e0140379. PubMed ID: 26473493
[TBL] [Abstract][Full Text] [Related]
6. The relationship of serum uric acid with non-alcoholic fatty liver disease.
Sertoglu E; Ercin CN; Celebi G; Gurel H; Kayadibi H; Genc H; Kara M; Dogru T
Clin Biochem; 2014 Apr; 47(6):383-8. PubMed ID: 24525254
[TBL] [Abstract][Full Text] [Related]
7. Determining the role for uric acid in non-alcoholic steatohepatitis development and the utility of urate metabolites in diagnosis: An opinion review.
Brennan P; Clare K; George J; Dillon JF
World J Gastroenterol; 2020 Apr; 26(15):1683-1690. PubMed ID: 32351286
[TBL] [Abstract][Full Text] [Related]
8. Hyperuricemia is associated with nonalcoholic fatty liver disease activity score in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Jaruvongvanich V; Ahuja W; Wirunsawanya K; Wijarnpreecha K; Ungprasert P
Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1031-1035. PubMed ID: 28639970
[TBL] [Abstract][Full Text] [Related]
9. The xanthine oxidase inhibitor febuxostat suppresses development of nonalcoholic steatohepatitis in a rodent model.
Nakatsu Y; Seno Y; Kushiyama A; Sakoda H; Fujishiro M; Katasako A; Mori K; Matsunaga Y; Fukushima T; Kanaoka R; Yamamotoya T; Kamata H; Asano T
Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(1):G42-51. PubMed ID: 25999428
[TBL] [Abstract][Full Text] [Related]
10. Increased catabolism of nucleic acid in nonalcoholic fatty liver disease patients of different ages.
Tian CR; Qian L; Du CL; Shen XZ
Int J Biol Macromol; 2014 Apr; 65():107-9. PubMed ID: 24456899
[TBL] [Abstract][Full Text] [Related]
11. Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study.
Li Y; Xu C; Yu C; Xu L; Miao M
J Hepatol; 2009 May; 50(5):1029-34. PubMed ID: 19299029
[TBL] [Abstract][Full Text] [Related]
12. The prevalence of nonalcoholic fatty liver disease and relationship with serum uric acid level in Uyghur population.
Cai W; Song JM; Zhang B; Sun YP; Yao H; Zhang YX
ScientificWorldJournal; 2014; 2014():393628. PubMed ID: 24516367
[TBL] [Abstract][Full Text] [Related]
13. Hyperuricemia is not associated with severity of liver fibrosis in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Jaruvongvanich V; Ahuja W; Wijarnpreecha K; Ungprasert P
Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):694-697. PubMed ID: 28252464
[TBL] [Abstract][Full Text] [Related]
14. Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease.
Petta S; Cammà C; Cabibi D; Di Marco V; Craxì A
Aliment Pharmacol Ther; 2011 Oct; 34(7):757-66. PubMed ID: 21790685
[TBL] [Abstract][Full Text] [Related]
15. Association Of Non-Alcoholic Fatty Liver Disease With Serum Uric Acid.
Abbasi S; Haleem N; Jadoon S; Farooq A
J Ayub Med Coll Abbottabad; 2019; 31(1):64-66. PubMed ID: 30868786
[TBL] [Abstract][Full Text] [Related]
16. The Prevalence of Nonalcoholic Fatty Liver Disease and Related Metabolic Comorbidities Was Associated with Age at Onset of Moderate to Severe Plaque Psoriasis: A Cross-Sectional Study.
Xu X; Su L; Gao Y; Ding Y
PLoS One; 2017; 12(1):e0169952. PubMed ID: 28099469
[TBL] [Abstract][Full Text] [Related]
17. Gender effect of hyperuricemia on the development of nonalcoholic fatty liver disease (NAFLD): A clinical analysis and mechanistic study.
Xu K; Zhao X; Fu X; Xu K; Li Z; Miao L; Li Y; Cai Z; Qiao L; Bao J
Biomed Pharmacother; 2019 Sep; 117():109158. PubMed ID: 31252266
[TBL] [Abstract][Full Text] [Related]
18. Hepatic Accumulation of Hypoxanthine: A Link Between Hyperuricemia and Nonalcoholic Fatty Liver Disease.
Toledo-Ibelles P; Gutiérrez-Vidal R; Calixto-Tlacomulco S; Delgado-Coello B; Mas-Oliva J
Arch Med Res; 2021 Oct; 52(7):692-702. PubMed ID: 33966916
[TBL] [Abstract][Full Text] [Related]
19. [CORRECTION OF BILE FLOW CHARACTERISTICS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE IN COMBINATION WITH HYPERURICEMIA].
Barabanchyk OV; Svintsits'kyĭ AS; Kozak NP
Lik Sprava; 2014 Nov; (11):48-53. PubMed ID: 25528832
[TBL] [Abstract][Full Text] [Related]
20. Obesity interacts with hyperuricemia on the severity of non-alcoholic fatty liver disease.
Zhou M; Yang N; Xing X; Chang D; Li J; Deng J; Chen Y; Hu C; Zhang R; Lu X; Zhao Y; He Y
BMC Gastroenterol; 2021 Jan; 21(1):43. PubMed ID: 33509116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
